Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Microlight Corporation of America is a medical device company specializing in Low-Level Laser Therapy (LLLT), also known as cold laser therapy. The company is best known for its ML830 Laser, which was the first non-surgical, non-invasive laser to receive FDA clearance for the treatment of Carpal Tunnel Syndrome. Their technology utilizes specific wavelengths of light to stimulate cellular repair and reduce inflammation without generating heat. Microlight's products are widely used by physical therapists, chiropractors, and sports medicine professionals to manage chronic pain and accelerate tissue healing. The company's patented 830nm wavelength is designed to penetrate deep into the tissue to reach the affected areas effectively. Microlight continues to be a leader in the non-pharmacological pain management space, offering a safe alternative to surgery and opioids.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Microlight.